AI assistant
Sending…
SCHWAB CHARLES CORP — Director's Dealing 2022
Nov 14, 2022
10451_dirs_2022-11-14_1c126f51-d902-46cf-b230-349f7e0ca1b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SCHWAB CHARLES CORP (SCHW)
CIK: 0000316709
Period of Report: 2022-11-10
Reporting Person: Ellis Stephen A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-10 | Common Stock | M | 2685 | $13.67 | Acquired | 4899 | Direct |
| 2022-11-10 | Common Stock | M | 14345 | $19.21 | Acquired | 4899 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-10 | Nonqualified Stock Option (right to buy) | $13.67 | M | 2685 | Disposed | 2022-12-12 | Common Stock (2685) | Direct |
| 2022-11-10 | Nonqualified Stock Option (right to buy) | $19.21 | M | 14345 | Disposed | 2023-05-20 | Common Stock (14345) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 58657 | Indirect |
Footnotes
F1: Reflects the contribution of the shares received upon exercise of the option to a revocable living trust.
F2: The option was granted under the company's 2004 Stock Incentive Plan and vested 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date.
F3: The option was granted under the company's 2013 Stock Incentive Plan and vested 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date.
More from SCHWAB CHARLES CORP
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 8
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20